Customereye

Eurofins

Healthcare & Medical • United Kingdomwww.eurofins.com

Review data last updated .

Based on public reviews and response behavior.

Tip: Tap or click the ⓘ icons to learn how to read each section. Expand cards for evidence.

Overall Score

37/100
−16.7 vs. last month3.42 ★ average rating · 600 reviews

Competitive Performance Rank

Among fully-analyzed Healthcare & Medical companies

#593of 615
Top 96% · Bottom Tier
#1 (best)#615 (worst)
#591Peer
#592Peer
#593This company
#594Peer
#595Peer

Overall Customer Sentiment

Below Average

51% of reviews positive, 47% negative

51%
positive
  • Positive51%
  • Neutral2%
  • Negative47%

Sentiment Balance

Covering January 2023 — 4 reviews, not the company's full review history.

positive
  • Positive
  • Neutral
  • Negative

Takeaway: Positive sentiment accounts for 0% of reviews in this period, with 100% negative and 0% neutral.

Sentiment Trend Over Time

Reviews (Count)

Showing 579 reviews across the months with enough data to chart reliably (min 3/month), most recent: January 2023.

Sentiment has been declining over the period shown.

Theme Distribution

Share of theme mentions

Customer Support
19.1%
Response Speed
15.8%
Loyalty
12.8%
Delivery Shipping
11.2%
Pricing
9.9%

Most feedback concerns Customer Support.

The most common complaint theme is Customer Support, making up 19.1% of all theme mentions.

Churn Signal Score

Rule-based: negative-review share, churn-intent phrases, and sentiment movement over time.

HIGH60/100
60/100
signal score
  • Built from a negative-review share of 52.3% across this company's analyzed reviews.
  • 9 reviews contain phrases that signal intent to leave, such as cancelling or switching provider.
  • Recent reviews are less negative than earlier ones, which pulls the signal down.

Reviewer Breakdown

Star split and recent-versus-earlier sentiment.

3.4avg rating
5
48.7%
4
11.0%
3
5.2%
2
4.2%
1
31.0%

Based on 600 analyzed reviews. Sentiment is improving: 100.0% of reviews in the last three months were positive, compared with 0.0% in the three months before that.

Unlock full insights

Sign up to view detailed data and analysis